| Grant number: | 20/05761-3 |
| Support Opportunities: | Regular Research Grants |
| Start date: | July 01, 2020 |
| End date: | June 30, 2022 |
| Field of knowledge: | Biological Sciences - Biochemistry - Chemistry of Macromolecules |
| Principal Investigator: | Eduardo Maffud Cilli |
| Grantee: | Eduardo Maffud Cilli |
| Host Institution: | Instituto de Química (IQ). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil |
| City of the host institution: | Araraquara |
| Associated researchers: | Cintia Bittar Oliva ; Marilia de Freitas Calmon ; Norival Alves Santos Filho ; Paula Rahal ; Paulo Ricardo da Silva Sanches |
| Associated research grant: | 17/24839-0 - Nanoelectronics and nanoscale electrochemistry: fundaments and applications, AP.TEM |
| Associated scholarship(s): | 20/12519-4 - Study of the action of synthetic peptides as antivirals against SARS-CoV-2 (COVID-19) and combined evaluation with commercial anti-inflammatories, BP.PD |
Abstract
Human pandemics, emerging and re-emerging viruses and the mutation of viral strains have been highlighting the importance for antiviral research. Pandemics, such as the actual caused by SARS-CoV-2, directly affect the world, mainly the public health, economy, tourism, etc. Also, due his high and fast spreading, this disease are saturating hospitals worldwide and the number of deaths are increasing constantly. Due the actual severe global health problem caused by SARS-CoV-2 and moved for the urgency for the development of treatments for this disease and future pandemics, the search for new compounds to treat infections by SARS-Cov-2 represents an important research area. Therefore, the objective of this project is identify and evaluate potential peptides able to inhibit virus SARS-CoV-2 infection progression in different steps of virus replication in vitro such as virucidal, receptor binding and cytoplasmic replication. Peptides and bioconjugates have been showing high antiviral potential in different steps of virus lifecycle. According to antiviral activity, compounds will be classified within groups (Virucidal, Inhibitor of receptor binding and inhibitor of cytoplasmic replication) and the action mechanism will be elucidate. Additionally, selected peptides will be evaluated together with anti-inflammatories (Ibuprofen and Ketoprofen) to evaluate the combination of antiviral and anti-inflammatory therapies. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
BIOCONJUGAÇÃO DE GUANIDINAS N,N’,N’’-TRISUBSTITUÍDAS COM PEPTÍDEOS ANTIMICROBIANOS E USO DOS BIOCONJUGADOS BR 10 2022 022855-8 - Universidade Estadual Paulista Júlio de Mesquita Filho (Unesp) . Márcia Aparecida Silva Graminha; João Victor Marcelino De Souza; Luana Ribeiro Dos Anjos; Vitor Partite Moreira; Maria Carolina Oliveira De Arruda Brasil; Eduardo Rene Perez Gonzalez; Eduardo Maffud Cilli; Natália Caroline Costa Coelho - January 2022, 01